Precision Biosciences Inc financial data

Symbol
DTIL on Nasdaq
Location
Durham, NC
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 03 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 535 % +24.3%
Debt-to-equity 196 % -18%
Return On Equity -214 % -1313%
Return On Assets -72.2 % -1489%
Operating Margin -12.8K % -59318%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13.3M shares +72.8%
Common Stock, Shares, Outstanding 12.1M shares +61.5%
Entity Public Float 66.8M USD +13%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 11.8M shares +62.2%
Weighted Average Number of Shares Outstanding, Diluted 11.8M shares +62.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.26M USD -98.6%
Research and Development Expense 55.6M USD -2.5%
General and Administrative Expense 34.6M USD +0.95%
Operating Income (Loss) -89.5M USD -452%
Net Income (Loss) Attributable to Parent -83.6M USD -1070%
Earnings Per Share, Basic -9 USD/shares -5559%
Earnings Per Share, Diluted -9 USD/shares -6714%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 44.9M USD -54.6%
Marketable Securities, Current 0 USD -100%
Accounts Receivable, after Allowance for Credit Loss, Current 4K USD -97.9%
Other Assets, Current 848K USD +80%
Assets, Current 51.7M USD -53.2%
Deferred Income Tax Assets, Net 2.11M USD -35.6%
Property, Plant and Equipment, Net 2.03M USD -43.1%
Operating Lease, Right-of-Use Asset 6.14M USD -17%
Intangible Assets, Net (Excluding Goodwill) 985K USD +154%
Other Assets, Noncurrent 200K USD -10.7%
Assets 93.5M USD -39%
Accounts Payable, Current 1.34M USD +39.9%
Employee-related Liabilities, Current 3.16M USD -12.1%
Contract with Customer, Liability, Current 6.25M USD +3470%
Liabilities, Current 15M USD +25.2%
Contract with Customer, Liability, Noncurrent 20M USD -24.9%
Deferred Income Tax Liabilities, Net 2.11M USD -35.6%
Operating Lease, Liability, Noncurrent 5.3M USD -21.6%
Other Liabilities, Noncurrent 227K USD +20.7%
Liabilities 76.9M USD -13%
Retained Earnings (Accumulated Deficit) -548M USD -18%
Stockholders' Equity Attributable to Parent 16.6M USD -74.4%
Liabilities and Equity 93.5M USD -39%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -19.1M USD -0.37%
Net Cash Provided by (Used in) Financing Activities 10.7M USD -73.3%
Net Cash Provided by (Used in) Investing Activities -314K USD -1108%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 12.1M shares +61.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.68M USD -141%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 71.2M USD -41.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 340K USD -35.4%
Deferred Tax Assets, Valuation Allowance 137M USD -1.63%
Operating Lease, Liability 6.75M USD -15.9%
Lessee, Operating Lease, Liability, to be Paid 8.01M USD -19.6%
Property, Plant and Equipment, Gross 31.2M USD -2.08%
Operating Lease, Liability, Current 1.46M USD +14.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.08M USD +2.92%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.02M USD +2.91%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.25M USD -34.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.14M USD +2.98%
Deferred Tax Assets, Operating Loss Carryforwards 51.8M USD +13.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.27M USD -40.7%
Operating Lease, Payments 484K USD +4.76%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 11.7M USD -2.4%
Interest Expense 1.56M USD -31.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%